{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:15:35Z","timestamp":1795194935748,"version":"4.10.3"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Staphylococcus aureus infections have become a significant\npublic health issue due to increasing the resistance against known antibiotics, especially\nby Methicillin-Resistant Staphylococcus aureus (MRSA). Fluoroquinolones are broad-\n-spectrum class of antibiotics mostly utilized in treating various bacterial infections and\nthose caused by S. aureus. Reported data indicated that mutations of Ser84 to Leu,\nSer85 to Pro and Glu88 to Lys in DNA gyrase A enzyme are the major cause of fluoroquinolone\nresistance against S. aureus. Therefore, the development of a novel targeted\nmolecule with potential activity against mutant S. aureus is essential. The antibacterial\nactivity of quinoline-clubbed hydrazone derivatives against S. aureus is noteworthy.\nHowever, the mechanism of action of quinoline hydrazone derivatives has not been reported\nby inhibiting these common mutations of DNA gyrase A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this concern, some quinoline hydrazone derivatives as antibacterial agents\nreported by several research groups have been further studied as mutated S. aureus\nDNA gyrase A (Pdb id: 8bp2) inhibitors using in-silico techniques viz., molecular docking,\nMD simulation, DFT analysis, and ADMET predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among the studied compounds, 48 and 49 were found to be the most active and\nshowed the highest docking score (-9.29 kcalmol-1 and -8.47 kcalmol-1, respectively) by\ninteraction with mutant (Leu84 and Pro85) of S. aureus DNA gyrase A. Further, MD simulation\nresults indicated that both compounds exhibited good stability with the targeted\nmacromolecule under dynamic conditions. The most active compound 49 (\u028cE =\n0.159 eV) attributed to its lower HOMO-LUMO gap, which was an indicator of a potential\ninhibitor of fluoroquinolone- resistant S. aureus DNA gyrase A enzyme. ADMET\nprediction study emphasized that both compounds showed a significant safety profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The future perspective emphasized that compounds 48 and 49 could be developed\nas novel inhibitors against fluoroquinolone-resistant DNA gyrase A enzyme on\nthe completion of drug discovery approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673370267250607160438","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:52:07Z","timestamp":1750927927000},"page":"958-982","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quinoline Heterocyclic Clubbed Hydrazone Derivatives as Potential Inhibitors of Mutant S. aureus DNA Gyrase A; An In Silico Drug Discovery Approach -Molecular Docking, MD Simulation, DFT Analysis and ADMET Predictions"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-5818","authenticated-orcid":true,"given":"Sangeeta","family":"Verma","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, 136119, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-7712","authenticated-orcid":true,"given":"Sukhbir","family":"Lal","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, 136119, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-3146","authenticated-orcid":true,"given":"Rakesh","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Gurugram University, Gurugram, Haryana, 122003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-5475","authenticated-orcid":true,"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, 140401, Rajpura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-586X","authenticated-orcid":true,"given":"Tanuj","family":"Hooda","sequence":"additional","affiliation":[{"name":"MM College ofPharmacy, Maharshi Markandeshwar University Mullana, Ambala, Haryana, 133207, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e1004264","DOI":"10.1371\/journal.pmed.1004264","volume":"20","author":"Walsh T.R.","year":"2023","unstructured":"Walsh T.R.; Gales A.C.; Laxminarayan R.; Dodd P.C.; Antimicrobial resistance: Addressing a global threat to humanity. PLoS Med  2023,20(7),e1004264","journal-title":"PLoS Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(22)00796-4","volume":"23","author":"Patel J.","year":"2023","unstructured":"Patel J.; Harant A.; Fernandes G.; Mwamelo A.J.; Hein W.; Dekker D.; Sridhar D.; Measuring the global response to antimicrobial resistance, 2020\u201321: A systematic governance analysis of 114 countries. Lancet Infect Dis  2023,23(6),706-718","journal-title":"Lancet Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/jac\/dkr555","volume":"67","author":"Lafaurie M.","year":"2012","unstructured":"Lafaurie M.; Porcher R.; Donay J.; Resistant Pseudomonas aeruginosa isolation rates: A 10 year study. J Antimicrob Chemother  2012,67,1010-1015","journal-title":"J Antimicrob Chemother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.drup.2024.101147","volume":"77","author":"Brdov\u00e1 D.","year":"2024","unstructured":"Brdov\u00e1 D.; Ruml T.; Viktorov\u00e1 J.; Mechanism of staphylococcal resistance to clinically relevant antibiotics. Drug Resist Updat  2024,77,101147","journal-title":"Drug Resist Updat"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.3390\/ijms23158088","volume":"23","author":"Mlynarczyk-Bonikowska B.","year":"2022","unstructured":"Mlynarczyk-Bonikowska B.; Kowalewski C.; Krolak-Ulinska A.; Marusza W.; Molecular mechanisms of drug resistance in Staphylococcus aureus. Int J Mol Sci  2022,23(15),8088","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/antibiotics11050606","volume":"11","author":"Nandhini P.","year":"2022","unstructured":"Nandhini P.; Kumar P.; Mickymaray S.; Alothaim A.S.; Somasundaram J.; Rajan M.; Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) treatment: A review. Antibiotics  2022,11(5),606","journal-title":"Antibiotics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s42770-021-00566-4","volume":"52","author":"Rai A.","year":"2021","unstructured":"Rai A.; Khairnar K.; Overview of the risks of Staphylococcus aureus infections and their control by bacteriophages and bacteriophage-encoded products. Braz J Microbiol  2021,52(4),2031-2042","journal-title":"Braz J Microbiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C9MD00120D","volume":"10","author":"Pham T.D.M.","year":"2019","unstructured":"Pham T.D.M.; Ziora Z.M.; Blaskovich M.A.T.; Quinolone antibiotics. MedChemComm  2019,10(10),1719-1739","journal-title":"MedChemComm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1021\/acs.jproteome.9b00410","volume":"18","author":"Du G.F.","year":"2019","unstructured":"Du G.F.; Zheng Y.D.; Chen J.; He Q.Y.; Sun X.; Novel mechanistic insights into bacterial fluoroquinolone resistance. J Proteome Res  2019,18(11),3955-3966","journal-title":"J Proteome Res"},{"key":"ref=10","first-page":"1386","volume":"8","author":"Yang X.","year":"2015","unstructured":"Yang X.; Xing B.; Liang C.; Ye Z.; Zhang Y.; Prevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med  2015,8(1),1386-1390","journal-title":"Int J Clin Exp Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1128\/jb.172.12.7260-7262.1990","volume":"172","author":"Sreedharan S.","year":"1990","unstructured":"Sreedharan S.; Oram M.; Jensen B.; Peterson L.R.; Fisher L.M.; DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: Close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol  1990,172(12),7260-7262","journal-title":"J Bacteriol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines11020371","volume":"11","author":"Spencer A.C.","year":"2023","unstructured":"Spencer A.C.; Panda S.S.; DNA gyrase as a target for quinolones. Biomedicines  2023,11(2),371","journal-title":"Biomedicines"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1128\/AAC.38.9.2014","volume":"38","author":"Ito H.","year":"1994","unstructured":"Ito H.; Yoshida H.; Bogaki-Shonai M.; Niga T.; Hattori H.; Nakamura S.; Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother  1994,38(9),2014-2023","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.26850\/1678-4618eqj.v48.1.2023.p55-71","volume":"48","author":"Erazua E.A.","year":"2023","unstructured":"Erazua E.A.; Oyebamiji A.K.; Akintelu S.A.; Adewole P.D.; Adelakun A.; Adeleke B.B.; Quantitative structure-activity relationship, molecular docking and ADMET screening of tetrahydroquinoline derivatives as anti-small cell lung cancer agents. Ecl\u00e9t Qu\u00edm  2023,48(1),55-71","journal-title":"Ecl\u00e9t Qu\u00edm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/pathogens11111354","volume":"11","author":"Afzal M.","year":"2022","unstructured":"Afzal M.; Vijay A.K.; Stapleton F.; Willcox M.; The relationship between ciprofloxacin resistance and genotypic changes in S. aureus ocular isolates. Pathogens  2022,11(11),1354","journal-title":"Pathogens"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"106795","DOI":"10.1016\/j.ijantimicag.2023.106795","volume":"61","author":"de la Rosa J.M.O.","year":"2023","unstructured":"de la Rosa J.M.O.; Fern\u00e1ndez M.A.; Rodr\u00edguez-Villodres \u00c1.; Casimiro-Soriguer C.S.; Cisneros J.M.; Lepe J.A.; High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus. Int J Antimicrob Agents  2023,61(6),106795","journal-title":"Int J Antimicrob Agents"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/08927022.2024.2332453","volume":"50","author":"Saha S.","year":"2024","unstructured":"Saha S.; Tiwari H.; Ghosh M.; Molecular dynamics simulation guided analysis of the interaction between delafloxacin and Staphylococcus aureus gyrase mutants. Mol Simul  2024,50(10),601-612","journal-title":"Mol Simul"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"112438","DOI":"10.1016\/j.ejmech.2020.112438","volume":"200","author":"Sharma S.","year":"2020","unstructured":"Sharma S.; Kumar D.; Singh G.; Monga V.; Kumar B.; Recent advancements in the development of heterocyclic anti-inflammatory agents. Eur J Med Chem  2020,200,112438","journal-title":"Eur J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11164-017-3157-3","volume":"44","author":"Dofe V.S.","year":"2018","unstructured":"Dofe V.S.; Sarkate A.P.; Azad R.; Gill C.H.; Green synthesis and inhibitory effect of novel quinoline based thiazolidinones on the growth of MCF-7 human breast cancer cell line by G2\/M cell cycle arrest. Res Chem Intermed  2018,44(2),1149-1160","journal-title":"Res Chem Intermed"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"18207","DOI":"10.1039\/D2NJ02962F","volume":"46","author":"Elrayess R.","year":"2022","unstructured":"Elrayess R.; Darwish K.M.; Nafie M.S.; El-Sayyed G.S.; Said M.M.; Yassen A.S.A.; Quinoline\u2013hydrazone hybrids as dual mutant EGFR inhibitors with promising metallic nanoparticle loading: Rationalized design, synthesis, biological investigation and computational studies. New J Chem  2022,46(38),18207-18232","journal-title":"New J Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s43094-021-00391-4","volume":"8","author":"Mistry S.","year":"2022","unstructured":"Mistry S.; Singh A.K.; Synthesis and in vitro antimicrobial activity of new steroidal hydrazone derivatives. Future J Pharm Sci  2022,8(1),7","journal-title":"Future J Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/14756366.2015.1005012","volume":"31","author":"Puskullu M.O.","year":"2016","unstructured":"Puskullu M.O.; Shirinzadeh H.; Nenni M.; Gurer-Orhan H.; Suzen S.; Synthesis and evaluation of antioxidant activity of new quinoline-2-carbaldehyde hydrazone derivatives: Bioisosteric melatonin analogues. J Enzyme Inhib Med Chem  2016,31(1),121-125","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e117192","volume":"71","author":"Abdullah A.H.","year":"2024","unstructured":"Abdullah A.H.; Alarareh A.K.; Al-Sha\u2019er M.A.; Habashneh A.Y.; Awwadi F.F.; Bardaweel S.K.; Docking, synthesis, and anticancer assessment of novel quinoline-amidrazone hybrids. Pharmacia  2024,71,1-12","journal-title":"Pharmacia"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2300426","DOI":"10.1002\/ardp.202300426","volume":"357","author":"\u0106ur\u010di\u0107 V.","year":"2024","unstructured":"\u0106ur\u010di\u0107 V.; Olszewski M.; Maciejewska N.; Vi\u0161njevac A.; Srdi\u0107-Raji\u0107 T.; Dobri\u010di\u0107 V.; Garc\u00eda-Sosa A.T.; Kokanov S.B.; Ara\u0161kov J.B.; Silvestri R.; Sch\u00fcle R.; Jung M.; Nikoli\u0107 M.; Filipovi\u0107 N.R.; Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition. Arch Pharm  2024,357(2),2300426","journal-title":"Arch Pharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/153015","volume":"2015","author":"Mandewale M.C.","year":"2015","unstructured":"Mandewale M.C.; Thorat B.; Shelke D.; Yamgar R.; Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu(II) and Zn(II) complexes against Mycobacterium tuberculosis. Bioinorg Chem Appl  2015,2015,1-14","journal-title":"Bioinorg Chem Appl"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"126881","DOI":"10.1016\/j.bmcl.2019.126881","volume":"30","author":"Marra R.K.F.","year":"2020","unstructured":"Marra R.K.F.; K\u00fcmmerle A.E.; Guedes G.P.; Barros C.S.; Gomes R.S.P.; Cirne-Santos C.C.; Paix\u00e3o I.C.N.P.; Neves A.P.; Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors. Bioorg Med Chem Lett  2020,30(2),126881","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejps.2019.04.016","volume":"134","author":"Debnath U.","year":"2019","unstructured":"Debnath U.; Mukherjee S.; Joardar N.; Sinha Babu S.P.; Jana K.; Misra A.K.; Aryl quinolinyl hydrazone derivatives as anti-inflammatory agents that inhibit TLR4 activation in the macrophages. Eur J Pharm Sci  2019,134,102-115","journal-title":"Eur J Pharm Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1038\/s41598-023-32889-7","volume":"13","author":"Shayegan N.","year":"2023","unstructured":"Shayegan N.; Haghipour S.; Tanideh N.; Moazzam A.; Mojtabavi S.; Faramarzi M.A.; Irajie C.; Parizad S.; Ansari S.; Larijani B.; Hosseini S.; Iraji A.; Mahdavi M.; Synthesis, in vitro \u03b1-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents. Sci Rep  2023,13(1),6304","journal-title":"Sci Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1016\/j.bmc.2019.07.035","volume":"27","author":"Taha M.","year":"2019","unstructured":"Taha M.; Sultan S.; Imran S.; Rahim F.; Zaman K.; Wadood A.; Ur Rehman A.; Uddin N.; Mohammed Khan K.; Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies. Bioorg Med Chem  2019,27(18),4081-4088","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.3390\/molecules28186471","volume":"28","author":"Magwaza R.N.","year":"2023","unstructured":"Magwaza R.N.; Abubaker M.; Hussain B.; Haley M.; Couper K.; Freeman S.; Nirmalan N.J.; Evaluation of 4-Aminoquinoline hydrazone analogues as potential leads for drug-resistant malaria. Molecules  2023,28(18),6471","journal-title":"Molecules"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"113271","DOI":"10.1016\/j.ejmech.2021.113271","volume":"215","author":"Marinho J.A.","year":"2021","unstructured":"Marinho J.A.; Martins Guimar\u00e3es D.S.; Glanzmann N.; de Almeida Pimentel G.; Karine da Costa Nunes I.; Gualberto Pereira H.M.; Navarro M.; de Pilla Varotti F.; David da Silva A.; Abramo C.; In vitro and in vivo antiplasmodial activity of novel quinoline derivative compounds by molecular hybridization. Eur J Med Chem  2021,215,113271","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejps.2016.12.011","volume":"99","author":"Sonawane S.J.","year":"2017","unstructured":"Sonawane S.J.; Kalhapure R.S.; Govender T.; Hydrazone linkages in pH responsive drug delivery systems. Eur J Pharm Sci  2017,99,45-65","journal-title":"Eur J Pharm Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1900086","DOI":"10.1002\/ardp.201900086","volume":"352","author":"Rizk O.H.","year":"2019","unstructured":"Rizk O.H.; Bekhit M.G.; Hazzaa A.A.B.; El-Khawass E.S.M.; Abdelwahab I.A.; Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids. Arch Pharm  2019,352(10),1900086","journal-title":"Arch Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/antibiotics11111507","volume":"11","author":"Elmongy E.I.","year":"2022","unstructured":"Elmongy E.I.; Ahmed A.A.S.; El Sayed I.E.T.; Fathy G.; Awad H.M.; Salman A.U.; Hamed M.A.; Hamed M.A.; Synthesis, biocidal and antibiofilm activities of new isatin\u2013quinoline conjugates against multidrug-resistant bacterial pathogens along with their in silico screening. Antibiotics  2022,11(11),1507","journal-title":"Antibiotics"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e202200571","DOI":"10.1002\/cmdc.202200571","volume":"18","author":"Verma S.","year":"2023","unstructured":"Verma S.; Lal S.; Narang R.; Sudhakar K.; Quinoline hydrazide\/hydrazone derivatives: Recent insights on antibacterial activity and mechanism of action. ChemMedChem  2023,18(5),e202200571","journal-title":"ChemMedChem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/bib\/bbz103","volume":"21","author":"Agamah F.E.","year":"2020","unstructured":"Agamah F.E.; Mazandu G.K.; Hassan R.; Bope C.D.; Thomford N.E.; Ghansah A.; Chimusa E.R.; Computational\/in silico methods in drug target and lead prediction. Brief Bioinform  2020,21(5),1663-1675","journal-title":"Brief Bioinform"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4155\/fmc.13.207","volume":"6","author":"Kharkar P.S.","year":"2014","unstructured":"Kharkar P.S.; Warrier S.; Gaud R.S.; Reverse docking: A powerful tool for drug repositioning and drug rescue. Future Med Chem  2014,6(3),333-342","journal-title":"Future Med Chem"},{"key":"ref=38","first-page":"207","volume":"13","author":"Tiwari A.","year":"2021","unstructured":"Tiwari A.; Singh S.; Computational approaches in drug designing. Bioinforma. Methods Appl  2021,13,207-217","journal-title":"Methods Appl"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"127670","DOI":"10.1016\/j.molstruc.2019.127670","volume":"1205","author":"Mohan A.","year":"2020","unstructured":"Mohan A.; Kirubakaran R.; Parray J.A.; Sivakumar R.; Murugesh E.; Govarthanan M.; Ligand-based pharmacophore filtering, atom based 3D-QSAR, virtual screening and ADME studies for the discovery of potential ck2 inhibitors. J Mol Struct  2020,1205,127670","journal-title":"J Mol Struct"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11030-022-10440-6","volume":"27","author":"Fidan O.","year":"2023","unstructured":"Fidan O.; Mujwar S.; Kciuk M.; Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing. Mol Divers  2023,27(1),463-475","journal-title":"Mol Divers"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00894-022-05185-w","volume":"28","author":"Mujwar S.","year":"2022","unstructured":"Mujwar S.; Tripathi A.; Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans. J Mol Model  2022,28(7),193","journal-title":"J Mol Model"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"Forli S.","year":"2016","unstructured":"Forli S.; Huey R.; Pique M.E.; Sanner M.F.; Goodsell D.S.; Olson A.J.; Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc  2016,11(5),905-919","journal-title":"Nat Protoc"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1109\/SC.2006.54","author":"Bowers K.J.","unstructured":"Bowers K.J.; Chow E.; Xu H.; Dror R.O.; Eastwood M.P.; Gregersen B.A.; Klepeis J.L.; Kolossvary I.; Moraes M.A.; Sacerdoti F.D.; Salmon J.K.; Shan Y.; Shaw D.E.; Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing  Tampa, FL, USA, 11-17 November 2006, pp. 43.","journal-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.3390\/molecules27206905","volume":"27","author":"Shinu P.","year":"2022","unstructured":"Shinu P.; Sharma M.; Gupta G.L.; Mujwar S.; Kandeel M.; Kumar M.; Nair A.B.; Goyal M.; Singh P.; Attimarad M.; Venugopala K.N.; Nagaraja S.; Telsang M.; Aldhubiab B.E.; Morsy M.A.; Computational design, synthesis, and pharmacological evaluation of naproxen-guaiacol chimera for gastro-sparing anti-inflammatory response by selective COX2 inhibition. Molecules  2022,27(20),6905","journal-title":"Molecules"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e202205735","DOI":"10.1002\/anie.202205735","volume":"61","author":"Bursch M.","year":"2022","unstructured":"Bursch M.; Mewes J.M.; Hansen A.; Grimme S.; Best-practice DFT protocols for basic molecular computational chemistry. Angew Chem Int Ed  2022,61(42),e202205735","journal-title":"Angew Chem Int Ed"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/B978-0-12-800536-1.00013-7","volume":"68","author":"Lafifi I.","year":"2014","unstructured":"Lafifi I.; Khatmi D.; Theoretical investigation of the intramolecular H-bonding on tautomerism. Adv Quantum Chem  2014,68,257-268","journal-title":"Adv Quantum Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11164-022-04910-7","volume":"49","author":"Thakur A.","year":"2023","unstructured":"Thakur A.; Verma M.; Setia P.; Bharti R.; Sharma R.; Sharma A.; Negi N.P.; Anand V.; Bansal R.; DFT analysis and in vitro studies of isoxazole derivatives as potent antioxidant and antibacterial agents synthesized via one-pot methodology. Res Chem Intermed  2023,49(3),859-883","journal-title":"Res Chem Intermed"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/s41598-024-54021-z","volume":"14","author":"Gul S.","year":"2024","unstructured":"Gul S.; Jan F.; Alam A.; Shakoor A.; Khan A.; AlAsmari A.F.; Alasmari F.; Khan M.; Bo L.; Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for \u03b1-glucosidase inhibition assessment. Sci Rep  2024,14(1),3419","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","volume":"15","author":"Kar S.","year":"2020","unstructured":"Kar S.; Leszczynski J.; Open access in silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov  2020,15(12),1473-1487","journal-title":"Expert Opin Drug Discov"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","volume":"25","author":"Jia C.Y.","year":"2020","unstructured":"Jia C.Y.; Li J.Y.; Hao G.F.; Yang G.F.; A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov Today  2020,25(1),248-258","journal-title":"Drug Discov Today"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.69980\/redvet.v25i1S.648","volume":"25","author":"Poongattil S.","year":"2024","unstructured":"Poongattil S.; Thomas J.; Joy C.; In silico analysis and molecular docking studies of potential compounds from Crateva Magna (Lour.) DC. using POAP. Rev Electr\u00f3n Vet  2024,25,298-313","journal-title":"Rev Electr\u00f3n Vet"},{"key":"ref=52","first-page":"1","author":"Bharwani H.","year":"2024","unstructured":"Bharwani H.; Kapur L.S.; Palani S.G.; Milk adulteration testing and analysis (MATA) kit for rapid detection of cow milk adulterated with urea and glucose at low cost. Res Squar  2024,1-27","journal-title":"Res Squar"},{"key":"ref=53","first-page":"2082","volume":"7","author":"Sharma M.","year":"2020","unstructured":"Sharma M.; Goyal R.; Ahuja D.; Sharma A.; Soni S.L.; Antimicrobial and antifungal activity of newly synthesized 4-hydroxy quinoline derivatives. Eur J Mol Clin Med  2020,7,2082-2094","journal-title":"Eur J Mol Clin Med"},{"key":"ref=54","first-page":"40","volume":"10","author":"Pradhan A.","year":"2018","unstructured":"Pradhan A.; Vishwakarma S.K.; Synthesis, characterisation and antimicrobial activity of schiff base of 7-Hydroxy-3-Methyl-2- Quinolone. Int J Recent Trends Sci Technol  2018,10(1),40-43","journal-title":"Int J Recent Trends Sci Technol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1080\/10406638.2020.1821230","volume":"42","author":"Celik I.","year":"2022","unstructured":"Celik I.; Erol M.; Puskullu M.O.; Uzunhisarcikli E.; Ince U.; Kuyucuklu G.; Suzen S.; In vitro and in silico studies of Quinoline-2-Carbaldehyde Hydrazone derivatives as potent antimicrobial agents. Polycycl Aromat Compd  2022,42(4),1942-1958","journal-title":"Polycycl Aromat Compd"},{"key":"ref=56","first-page":"114","volume":"2","author":"Dawood R.S.","year":"2012","unstructured":"Dawood R.S.; Synthesis, characterization and biological activity study of some new schiff bases derived from Phenyl Quinoline-2 (1H) -one. Al-Anbar. J Vet Sci  2012,2,114-122","journal-title":"J Vet Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00044-014-1254-z","volume":"24","author":"Kumar M.","year":"2015","unstructured":"Kumar M.; Kumar V.; Gupta G.K.; Synthesis, antibacterial evaluation, and SAR study of some novel 3-aryl\/heteroaryl-9-methyl-1,2,4-triazolo-[4,3-a]-quinoline derivatives. Med Chem Res  2015,24(5),1857-1868","journal-title":"Med Chem Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"104014","DOI":"10.1016\/j.bioorg.2020.104014","volume":"101","author":"Puskullu M.O.","year":"2020","unstructured":"Puskullu M.O.; Celik I.; Erol M.; Fatullayev H.; Uzunhisarcikli E.; Kuyucuklu G.; Antimicrobial and antiproliferative activity studies of some new quinoline-3-carbaldehyde hydrazone derivatives. Bioorg Chem  2020,101,104014","journal-title":"Bioorg Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ejmech.2017.07.004","volume":"138","author":"Abdelrahman M.A.","year":"2017","unstructured":"Abdelrahman M.A.; Salama I.; Gomaa M.S.; Elaasser M.M.; Abdel-Aziz M.M.; Soliman D.H.; Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents. Eur J Med Chem  2017,138,698-714","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00044-013-0655-8","volume":"23","author":"Makawana J.A.","year":"2014","unstructured":"Makawana J.A.; Sangani C.B.; Teraiya S.B.; Zhu H-L.; Schiff\u2019s base derivatives bearing 2-thiophenoxyquinoline nucleus as new antibacterial agents. Med Chem Res  2014,23(1),471-479","journal-title":"Med Chem Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"950","DOI":"10.7598\/cst2013.427","volume":"2","author":"Shaikh S.S.","year":"2013","unstructured":"Shaikh S.S.; Synthesis and antimicrobial activities of substituted benzohydrazide. Chem Sci Trans  2013,2,950-954","journal-title":"Chem Sci Trans"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/15257770802400081","volume":"27","author":"Lamani D.S.","year":"2008","unstructured":"Lamani D.S.; Venugopala Reddy K.R.; Bhojya Naik H.S.; Savyasachi A.; Naik H.R.; Synthesis and DNA binding studies of novel heterocyclic substituted quinoline schiff bases: A potent antimicrobial agent. Nucleosides Nucleotides Nucleic Acids  2008,27(10-11),1197-1210","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1570178616666181227122326","volume":"16","author":"Shabeeb I.","year":"2019","unstructured":"Shabeeb I.; Al-Essa L.; Shtaiwi M.; Al-Shalabi E.; Younes E.; Okasha R.; Abu Sini M.; New hydrazide-hydrazone derivatives of quinoline 3-carboxylic acid hydrazide: Synthesis, theoretical modeling and antibacterial evaluation. Lett Org Chem  2019,16(5),430-436","journal-title":"Lett Org Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/jhet.3322","volume":"55","author":"Hamama W.S.","year":"2018","unstructured":"Hamama W.S.; Ibrahim M.E.; Gooda A.A.; Zoorob H.H.; Efficient synthesis, antimicrobial, antioxidant assessments and geometric optimization calculations of azoles- incorporating quinoline moiety. J Heterocycl Chem  2018,55(11),2623-2634","journal-title":"J Heterocycl Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/00397911.2017.1309668","volume":"47","author":"Mallandur B.K.","year":"2017","unstructured":"Mallandur B.K.; Rangaiah G.; Harohally N.V.; Synthesis and antimicrobial activity of Schiff bases derived from 2-chloro quinoline-3-carbaldehyde and its derivatives incorporating 7-methyl-2-propyl-3 H -benzoimidazole-5-carboxylic acid hydrazide. Synth Commun  2017,47(11),1065-1070","journal-title":"Synth Commun"},{"key":"ref=66","first-page":"165","volume":"2","author":"El-gamal K.M.A.","year":"2015","unstructured":"El-gamal K.M.A.; Sherbiny F.F.; El-morsi A.M.; Design, synthesis and antimicrobial evaluation of some novel quinoline derivatives. Pharm Pharmacol Int J  2015,2,165-177","journal-title":"Pharm Pharmacol Int J"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s00044-014-1265-9","volume":"24","author":"Sharma A.","year":"2015","unstructured":"Sharma A.; Kumar V.; Khare R.; Gupta G.K.; Beniwal V.; Synthesis, docking study, and DNA photocleavage activity of some pyrimidinyl hydrazones and 3-(quinolin-3-yl)-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidine derivatives. Med Chem Res  2015,24(5),1830-1841","journal-title":"Med Chem Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"30864","DOI":"10.1039\/C4RA04456H","volume":"4","author":"Garudachari B.","year":"2014","unstructured":"Garudachari B.; Isloor A.M.; Satyanaraya M.N.; Ananda K.; Fun H.; RSC advances studies of some new trifluoromethyl Quinoline-3-. RSC Advances  2014,4,30864-30875","journal-title":"RSC Advances"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02772248.2014.918464","volume":"96","author":"Maddela S.","year":"2014","unstructured":"Maddela S.; Makula A.; Maddela R.; Synthesis of isatin\u2013quinoline conjugates as possible biologically active agents. Toxicol Environ Chem  2014,96(1),1-11","journal-title":"Toxicol Environ Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/PL00010299","volume":"131","author":"Kidwai M.","year":"2000","unstructured":"Kidwai M.; Sapra P.; Bhushan K.R.; Saxena R.K.; Gupta R.; Singh M.; Microwave assisted stereoselective synthesis and antibacterial activity of new Fluoroquinolinyl-\u03b2-lactam derivatives. Monatsh Chem  2000,131(1),85-90","journal-title":"Monatsh Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/hc-2020-0109","volume":"26","author":"T G S.","year":"2020","unstructured":"T G S.; Subramanian S.; Eswaran S.; Design, synthesis and study of antibacterial and antitubercular activity of quinoline hydrazone hybrids. Heterocycl Commun  2020,26(1),137-147","journal-title":"Heterocycl Commun"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"103406","DOI":"10.1016\/j.bioorg.2019.103406","volume":"94","author":"Katariya K.D.","year":"2020","unstructured":"Katariya K.D.; Shah S.R.; Reddy D.; Antimicrobial based hydrazone analogues: Synthesis, characterization and molecular docking. Bioorg Chem  2020,94,103406","journal-title":"Bioorg Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jhet.3080","volume":"55","author":"Patel D.B.","year":"2018","unstructured":"Patel D.B.; Vekariya R.H.; Patel K.D.; Vasava M.S.; Rajani D.P.; Rajani S.D.; Patel H.D.; Synthesis, docking, ADME-Tox Study of 2-(2-(2-Chlorophenyl)quinoline-4- carbonyl)- N -substituted hydrazinecarbothioamide derivatives and their biological evaluation. J Heterocycl Chem  2018,55(3),632-644","journal-title":"J Heterocycl Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1134\/S1070363217080321","volume":"87","author":"Bodke Y.D.","year":"2017","unstructured":"Bodke Y.D.; Shankerrao S.; Kenchappa R.; Telkar S.; Synthesis, antibacterial and antitubercular activity of novel Schiff bases of 2-(1-benzofuran-2-yl)quinoline-4-carboxylic acid derivatives. Russ J Gen Chem  2017,87(8),1843-1849","journal-title":"Russ J Gen Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"8568","DOI":"10.1039\/C6NJ03913H","volume":"41","author":"Bharadwaj S.S.","year":"2017","unstructured":"Bharadwaj S.S.; Poojary B.; Madan Kumar S.; Byrappa K.; Nagananda G.S.; Chaitanya A.K.; Zaveri K.; Yarla N.S.; Shiralgi Y.; Kudva A.K.; Dhananjaya B.L.; Design, synthesis and pharmacological studies of some new quinoline Schiff bases and 2,5-(disubstituted-[1,3,4])-oxadiazoles. New J Chem  2017,41(16),8568-8585","journal-title":"New J Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.1016\/j.bmc.2006.08.022","volume":"14","author":"Metwally K.A.","year":"2006","unstructured":"Metwally K.A.; Abdel-Aziz L.M.; Lashine E.S.M.; Husseiny M.I.; Badawy R.H.; Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorg Med Chem  2006,14(24),8675-8682","journal-title":"Bioorg Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.arabjc.2018.01.015","volume":"13","author":"Ajani O.O.","year":"2020","unstructured":"Ajani O.O.; Iyaye K.T.; Aderohunmu D.V.; Olanrewaju I.O.; Germann M.W.; Olorunshola S.J.; Bello B.L.; Microwave-assisted synthesis and antibacterial propensity of N\u2032-s-benzylidene-2-propylquinoline-4-carbohydrazide and N\u2032-((s-1H-pyrrol-2-yl)methylene)-2-propylquinoline-4-carbohydrazide motifs. Arab J Chem  2020,13(1),1809-1820","journal-title":"Arab J Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4301847","volume":"2018","author":"Le T.D.","year":"2018","unstructured":"Le T.D.; Pham N.N.; Nguyen T.C.; Preparation and antibacterial activity of some new 4-(2-Heterylidenehydrazinyl)-7-chloroquinoline derivatives. J Chem  2018,2018,1-7","journal-title":"J Chem"},{"key":"ref=79","first-page":"261","volume":"9","author":"Prateek P.","year":"2016","unstructured":"Prateek P.; Thakur A.; Shukla P.K.; Derivatives: Design, synthesis, characterization and antibacterial evaluation. Int J Chemtech Res  2016,9,261-269","journal-title":"Int J Chemtech Res"},{"key":"ref=80","first-page":"173","volume":"8","author":"Sreedhar P.","year":"2016","unstructured":"Sreedhar P.; Srinivas G.; Raju R.M.; Synthesis and antibacterial activity of N-substituted-1-benzyl- 1H -1, 2, 3- triazole-carbohydrazide derivatives. Der Pharma Chem  2016,8,173-178","journal-title":"Der Pharma Chem"},{"key":"ref=81","first-page":"575","volume":"9","author":"Thakur A.","year":"2016","unstructured":"Thakur A.; Gupta P.R.S.; Pathak P.; Kumar A.; Design, synthesis, SAR, docking and antibacterial evaluation: Aliphatic amide bridged 4-aminoquinoline clubbed 1, 2, 4- triazole derivatives. Int J Chemtech Res  2016,9,575-588","journal-title":"Int J Chemtech Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/03086648808072917","volume":"40","author":"Hafez A.A.A.","year":"1988","unstructured":"Hafez A.A.A.; Awad I.M.A.; Hassan K.M.; Synthesis and biological activity of some new 8-hydroxyquinoline sulphonamide derivatives. Phosphorus Sulfur Relat Elem  1988,40(3-4),219-225","journal-title":"Phosphorus Sulfur Relat Elem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"128305","DOI":"10.1016\/j.molstruc.2020.128305","volume":"1217","author":"Douadi K.","year":"2020","unstructured":"Douadi K.; Chafaa S.; Douadi T.; Al-Noaimi M.; Kaabi I.; Azoimine quinoline derivatives: Synthesis, classical and electrochemical evaluation of antioxidant, anti-inflammatory, antimicrobial activities and the DNA \/ BSA binding. J Mol Struct  2020,1217,128305","journal-title":"J Mol Struct"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18576\/ijnc\/020202","volume":"2","author":"Abdelmajeid A.","year":"2016","unstructured":"Abdelmajeid A.; Aly A.A.; Amine M.S.; Ghith A.A.; Synthesis and investigation of mass spectra and antimicrobial activity of some azoles and azines based on (QUINOLINE-8-YLOXY) ACETOHYDRAZIDE. Int J Nanomater Chem  2016,2(2),37-45","journal-title":"Int J Nanomater Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"64460","DOI":"10.1039\/C6RA09891F","volume":"6","author":"Sridhar P.","year":"2016","unstructured":"Sridhar P.; Alagumuthu M.; Arumugam S.; Reddy S.R.; Synthesis of quinoline acetohydrazide-hydrazone derivatives evaluated as DNA gyrase inhibitors and potent antimicrobial agents. RSC Advances  2016,6(69),64460-64468","journal-title":"RSC Advances"},{"key":"ref=86","first-page":"1100","volume":"1","author":"Revanasiddappa B.C.","year":"2009","unstructured":"Revanasiddappa B.C.; Subrahmanyam E.V.S.; Satyanarayana D.; Thomas J.; Sythesis and biological studies of some novel schiff bases and hydrazone derived from 8-hydroxy quinoline moiety. Int J Chemtech Res  2009,1,1100-1104","journal-title":"Int J Chemtech Res"},{"key":"ref=87","first-page":"74092","volume":"10","author":"Sangu S.","year":"2018","unstructured":"Sangu S.; Middha A.; Synthesis, antimicrobial and anticancer evaluation and molecular docking studies of some quinolyl heterocycles. Int J Curr Res  2018,10,74092-74095","journal-title":"Int J Curr Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/10406638.2023.2194653","volume":"44","author":"Nipate A.S.","year":"2024","unstructured":"Nipate A.S.; Jadhav C.K.; Chate A.V.; Dixit P.P.; Sharma P.; Gill C.H.; Synthesis and antimicrobial activity of new carbohydrazide bearing quinoline scaffolds in silico ADMET and molecular docking studies. Polycycl Aromat Compd  2024,44(2),1348-1365","journal-title":"Polycycl Aromat Compd"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1134\/S1068162024010254","volume":"50","author":"Vegal N.K.","year":"2024","unstructured":"Vegal N.K.; Bhatt T.D.; Kachhot K.; Joshi H.S.; Effective microwave-assisted synthesis of 2-Chloro-5,6-dimethyl-3-(((substituted-benzylidene)hydrazono)methyl)- quinoline and its biological assessment. Russ J Bioorganic Chem  2024,50(1),239-250","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"40140","DOI":"10.1021\/acsomega.3c03018","volume":"8","author":"\u00d6zcan E.","year":"2023","unstructured":"\u00d6zcan E.; Vagolu S.K.; G\u00fcnd\u00fcz M.G.; Stevanovic M.; K\u00f6kbudak Z.; T\u00f8njum T.; Nikodinovic-Runic J.; \u00c7etinkaya Y.; Do\u011fan \u015e.D.; Novel quinoline-based thiosemicarbazide derivatives: Synthesis, DFT calculations, and investigation of antitubercular, antibacterial, and antifungal activities. ACS Omega  2023,8(43),40140-40152","journal-title":"ACS Omega"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"17948","DOI":"10.1021\/acsomega.3c01156","volume":"8","author":"Abd El-Lateef H.M.","year":"2023","unstructured":"Abd El-Lateef H.M.; Elmaaty A.A.; Abdel Ghany L.M.A.; Abdel-Aziz M.S.; Zaki I.; Ryad N.; Design and synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide derivatives via molecular hybridization as novel microbial DNA-gyrase inhibitors. ACS Omega  2023,8(20),17948-17965","journal-title":"ACS Omega"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph14050399","volume":"14","author":"Al-wahaibi L.H.","year":"2021","unstructured":"Al-wahaibi L.H.; Amer A.A.; Marzouk A.A.; Gomaa H.A.M.; Youssif B.G.M.; Abdelhamid A.A.; Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors. Pharmaceutics  2021,14(5),399","journal-title":"Pharmaceutics"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.bmc.2017.01.007","volume":"25","author":"Alagumuthu M.","year":"2017","unstructured":"Alagumuthu M.; Arumugam S.; Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors\/antibacterial agents. Bioorg Med Chem  2017,25(4),1448-1455","journal-title":"Bioorg Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1021\/acscombsci.0c00060","volume":"22","author":"Upadhyay R.","year":"2020","unstructured":"Upadhyay R.; Kumar R.; Jangra M.; Rana R.; Nayal O.S.; Nandanwar H.; Maurya S.K.; Synthesis of bioactive complex small molecule\u2013ciprofloxacin conjugates and evaluation of their antibacterial activity. ACS Comb Sci  2020,22(9),440-445","journal-title":"ACS Comb Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1039\/C9DT03948A","volume":"49","author":"Szczupak \u0141.","year":"2020","unstructured":"Szczupak \u0141.; Kowalczyk A.; Trzybi\u0144ski D.; Wo\u017aniak K.; Mendoza G.; Arruebo M.; Steverding D.; St\u0105czek P.; Kowalski K.; Organometallic ciprofloxacin conjugates with dual action: Synthesis, characterization, and antimicrobial and cytotoxicity studies. Dalton Trans  2020,49(5),1403-1415","journal-title":"Dalton Trans"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e00567-19","DOI":"10.1128\/JCM.00567-19","volume":"57","author":"Miller A.A.","year":"2019","unstructured":"Miller A.A.; Traczewski M.M.; Huband M.D.; Bradford P.A.; Mueller P.; Determination of MIC quality control ranges for the novel gyrase inhibitor zoliflodacin. J Clin Microbiol  2019,57(9),e00567-19","journal-title":"J Clin Microbiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s11224-022-02111-x","volume":"34","author":"Er-rajy M.","year":"2023","unstructured":"Er-rajy M.; Fadili M.E.; Mujwar S.; Lenda F.Z.; Zarougui S.; Elhallaoui M.; QSAR, molecular docking, and molecular dynamics simulation\u2013based design of novel anti-cancer drugs targeting thioredoxin reductase enzyme. Struct Chem  2023,34(4),1527-1543","journal-title":"Struct Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e09777","DOI":"10.1016\/j.heliyon.2022.e09777","volume":"8","author":"Ahmed Juvale I.I.","year":"2022","unstructured":"Ahmed Juvale I.I.; Abdul Hamid A.A.; Abd Halim K.B.; Che Has A.T.; P-glycoprotein: New insights into structure, physiological function, regulation and alterations in disease. Heliyon  2022,8(6),e09777","journal-title":"Heliyon"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.dmpk.2016.07.002","volume":"32","author":"Mi J.","year":"2017","unstructured":"Mi J.; Zhao M.; Yang S.; Jia Y.; Wang Y.; Wang B.; Jin J.; Wang X.; Xiao Q.; Hu J.; Li Y.; Identification of cytochrome P450 isoforms involved in the metabolism of Syl930, a selective S1PR agonist acting as a potential therapeutic agent for autoimmune encephalitis. Drug Metab Pharmacokinet  2017,32(1),53-60","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22270\/jddt.v12i1-S.5222","volume":"12","author":"Krishnaveni K.","year":"2022","unstructured":"Krishnaveni K.; Sabitha M.; Murugan M.; Kandeepan C.; Ramya S.; Loganathan T.; Jayakumararaj R.; vNN model cross validation towards accuracy, sensitivity, specificity and kappa performance measures of \u03b2-caryophyllene using a restricted-unrestricted applicability domain on artificial intelligence and machine learning approach based in silico prediction. J Drug Deliv Ther  2022,12(1-S),123-131","journal-title":"J Drug Deliv Ther"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/B978-0-7216-8178-8.10002-8","author":"Chew D.J.","year":"2011","unstructured":"Chew D.J.; DiBartola S.P.; Schenck P.A.; Clinical evaluation of the urinary tract. Canine and Feline Nephrology and Urology  2011,32-62","journal-title":"Canine and Feline Nephrology and Urology"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673370267250607160438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/242997\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673370267250607160438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:28:49Z","timestamp":1771216129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/242997\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673370267250607160438","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1970-01-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}